Get the Stockscreener App
8.40
0.47%
-0.04
Tango Therapeutics Inc stock is traded at $8.40, with a volume of 3.42M.
It is down -0.47% in the last 24 hours and up +25.19% over the past month.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.
See More
Previous Close:
$8.44
Open:
$8.43
24h Volume:
3.42M
Relative Volume:
1.65
Market Cap:
$934.59M
Revenue:
$24.30M
Net Income/Loss:
$-145.57M
P/E Ratio:
-6.3158
EPS:
-1.33
Net Cash Flow:
$-149.17M
1W Performance:
+15.38%
1M Performance:
+25.19%
6M Performance:
+513.14%
1Y Performance:
+9.09%
1-Day Range:
$8.31
$8.79
1-Week Range:
$7.36
$8.80
52-Week Range:
$1.03
$8.80
Tango Therapeutics Inc Stock (TNGX) Company Profile
Name
Tango Therapeutics Inc
Sector
Industry
Phone
(857) 320-4900
Address
201 BROOKLINE AVENUE, BOSTON
Compare TNGX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TNGX
Tango Therapeutics Inc
|
8.40 | 939.04M | 24.30M | -145.57M | -149.17M | -1.33 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.64 | 101.35B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.00 | 58.66B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
562.27 | 59.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
737.56 | 44.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
340.70 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Tango Therapeutics Inc Stock (TNGX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-19-25 | Initiated | Piper Sandler | Overweight |
| Jul-17-24 | Initiated | Jefferies | Buy |
| Apr-04-24 | Initiated | Cantor Fitzgerald | Overweight |
| Feb-12-24 | Initiated | Piper Sandler | Overweight |
| Dec-08-23 | Initiated | B. Riley Securities | Buy |
| Oct-20-22 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Sep-20-21 | Initiated | SVB Leerink | Outperform |
View All
Tango Therapeutics Inc Stock (TNGX) Latest News
Published on: 2025-09-30 20:19:16 - newser.com
Building trade automation scripts for Tango Therapeutics Inc.Quarterly Portfolio Review & Low Volatility Stock Suggestions - newser.com
How to use Fibonacci retracement on Tango Therapeutics Inc.July 2025 Setups & Safe Capital Growth Stock Tips - newser.com
Published on: 2025-09-30 04:30:06 - newser.com
Published on: 2025-09-30 03:51:20 - newser.com
Major Shareholder Sells Off Tango Therapeutics Stock in Multi-Million Dollar Deal! - TipRanks
Tango Therapeutics (NASDAQ:TNGX) Major Shareholder Rock Ventures Iv L.P. Third Sells 500,000 Shares - MarketBeat
Multi factor analysis applied to Tango Therapeutics Inc.July 2025 Weekly Recap & Stock Portfolio Risk Control - newser.com
Tango Therapeutics, Inc. $TNGX Position Reduced by Goldman Sachs Group Inc. - Defense World
Tango Therapeutics Hits New 52-Week High at $8.56 - Markets Mojo
Real time social sentiment graph for Tango Therapeutics Inc.Trade Signal Summary & Free Community Supported Trade Ideas - newser.com
Is Tango Therapeutics Inc. building a consolidation baseBear Alert & Daily Entry Point Trade Alerts - newser.com
Regression analysis insights on Tango Therapeutics Inc. performanceJuly 2025 Setups & Low Risk Profit Maximizing Plans - newser.com
Published on: 2025-09-28 23:18:47 - newser.com
Tango Therapeutics Hits Day High with Strong 7.14% Intraday Surge - Markets Mojo
Is Tango Therapeutics Inc a good long term investmentMoving Average Crossovers & Options Trading Analysis Tools - earlytimes.in
Published on: 2025-09-28 04:16:53 - newser.com
Chart based analysis of Tango Therapeutics Inc. trendsTrade Analysis Report & Verified Swing Trading Watchlist - newser.com
Tango Therapeutics Hits New 52-Week High of $8.19, Marking Major Milestone - Markets Mojo
Quantitative breakdown of Tango Therapeutics Inc. recent moveWeekly Loss Report & Long-Term Capital Growth Strategies - newser.com
Tango Therapeutics (NASDAQ:TNGX) Sets New 1-Year HighTime to Buy? - MarketBeat
Tango Therapeutics (NASDAQ:TNGX) Shares Up 7%What's Next? - MarketBeat
Tango Therapeutics (NASDAQ:TNGX) Shares Down 5.2%Should You Sell? - MarketBeat
Tango Therapeutics, Inc. $TNGX Shares Acquired by Acadian Asset Management LLC - MarketBeat
What to expect from Tango Therapeutics Inc. in the next 30 daysAnalyst Upgrade & Weekly Return Optimization Plans - newser.com
Insider Selling: Tango Therapeutics (NASDAQ:TNGX) Major Shareholder Sells 363,541 Shares of Stock - MarketBeat
Leading vs lagging indicators on Tango Therapeutics Inc. performanceWeekly Trade Review & Smart Investment Allocation Tips - newser.com
Tango Therapeutics (NASDAQ:TNGX) Trading 5.5% HigherWhat's Next? - MarketBeat
Earnings visualization tools for Tango Therapeutics Inc.Market Activity Recap & AI Optimized Trade Strategies - newser.com
Using economic indicators to assess Tango Therapeutics Inc. potentialMarket Performance Recap & Expert Verified Movement Alerts - newser.com
Earnings Miss: Will Tango Therapeutics Inc benefit from rising consumer demand2025 Macro Impact & Low Volatility Stock Recommendations - خودرو بانک
Chart Watch: Is AN2 Therapeutics Inc. stock a good dividend stock2025 Top Decliners & Low Risk Profit Maximizing Plans - خودرو بانک
Can Tango Therapeutics Inc. recover in the next quarterJuly 2025 Levels & High Accuracy Buy Signal Tips - newser.com
Stock Analysis: What is Tango Therapeutics Incs market positionJuly 2025 Drop Watch & Free Growth Oriented Trading Recommendations - خودرو بانک
Growth Report: Is Tango Therapeutics Inc stock a good dividend stockOptions Play & Community Verified Trade Signals - خودرو بانک
Breakouts Watch: Is Tango Therapeutics Inc stock good for income investorsTrade Exit Summary & Entry Point Confirmation Signals - خودرو بانک
How to integrate Tango Therapeutics Inc. into portfolio analysis tools - newser.com
Volume Recap: Is Tango Therapeutics Inc in a long term uptrendJuly 2025 Final Week & Consistent Profit Trade Alerts - خودرو بانک
Tango Therapeutics Inc Stock (TNGX) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.36%
1.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):